-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LnRPlAxZjR/M+KGrHQtzOtU6Cp/M9E0X/tm/lDAgBhTU3j2s3jdPI7s0HKUHczPH Z4dEa8ZIvHa+BcxWHlhwEw== 0001181431-09-059205.txt : 20091230 0001181431-09-059205.hdr.sgml : 20091230 20091230170456 ACCESSION NUMBER: 0001181431-09-059205 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091228 FILED AS OF DATE: 20091230 DATE AS OF CHANGE: 20091230 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: INVESTOR GROWTH CAPITAL LTD CENTRAL INDEX KEY: 0001237710 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33095 FILM NUMBER: 091266994 BUSINESS ADDRESS: STREET 1: C/O INVESTOR GROWTH INC STREET 2: 12 E 49TH STREET 27 FL CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125159000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070336 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-624-7000 MAIL ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: INVESTOR AB CENTRAL INDEX KEY: 0000889232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33095 FILM NUMBER: 091266995 BUSINESS ADDRESS: STREET 1: ARAENALSGATAN SC STREET 2: S-103 32 CITY: STOCKHOLM SWEDEN STATE: V7 ZIP: 00000 BUSINESS PHONE: 310 2291000 MAIL ADDRESS: STREET 1: ARAENALSGATAN SC STREET 2: S-103 32 CITY: STOCKHOLM STATE: V7 ZIP: 15222 4 1 rrd261185.xml FORM 4 X0303 4 2009-12-28 0 0001070336 ACHILLION PHARMACEUTICALS INC ACHN 0000889232 INVESTOR AB ARSENALSGATAN 8C S-103 STOCKHOLM V7 SWEDEN 0 0 1 0 0001237710 INVESTOR GROWTH CAPITAL LTD CANADA COURT UPLAND ROAD, ST. PETER PORT GUERNSEY, CHANNEL ISLANDS X0 GY1 3BQ UNITED KINGDOM 0 0 1 0 Common Stock 2009-12-28 4 S 0 42446 3.1842 D 2281214 I See Footnote Common Stock 2009-12-28 4 S 0 29712 3.1842 D 1596860 D Common Stock 2009-12-29 4 S 0 105500 3.15 D 2175714 I See Footnote Common Stock 2009-12-29 4 S 0 73850 3.15 D 1523010 D 29,712 shares of Common Stock, par value $0.001 (the "Common Stock"), were sold by Investor Growth Capital Limited and 12,734 shares of Common Stock were sold by Investor Group, L.P. The shares of Common Stock reported in Column 5 are held directly by Investor Growth Capital Limited and Investor Group, L.P. Investor Growth Capital Limited is an indirect wholly-owned subsidiary of Investor AB. Investor Group, L.P. is a limited partnership of which Investor AB is the indirect general partner. Investor AB may be deemed to beneficially own the securities held by Investor Growth Capital Limited and Investor Group, L.P. Investor AB disclaims beneficial ownership of such securities except to the extent of its pecuniary interest in such securities. These shares of Common Stock were sold by Investor Growth Capital Limited. 73,850 shares of Common Stock were sold by Investor Growth Capital Limited and 31,650 shares of Common Stock were sold by Investor Group, L.P. The shares of Common Stock reported in Column 5 are held directly by Investor Growth Capital Limited and Investor Group, L.P. Investor Growth Capital Limited is an indirect wholly-owned subsidiary of Investor AB. Investor Group, L.P. is a limited partnership of which Investor AB is the indirect general partner. Investor AB may be deemed to beneficially own the securities held by Investor Growth Capital Limited and Investor Group, L.P. Investor AB disclaims beneficial ownership of such securities except to the extent of its pecuniary interest in such securities. These shares of Common Stock were sold by Investor Growth Capital Limited. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.18 to $3.202. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.10 to $3.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Michael Oporto 2009-12-30 /s/ Stephen Campe 2009-12-30 -----END PRIVACY-ENHANCED MESSAGE-----